← Back
Data updated: Mar 10, 2026
LEO PHARMA AS
DermatologyImmunologyOncology
LEO PHARMA AS is a major pharmaceutical company focused on Dermatology, Immunology, Oncology. Key products include ADBRY.
1993
Since
9
Drugs
-
Trials
6
Approved (2yr)
Key Drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 66%
2 drugs Phase 3: 17 Phase 2: 14 Phase 1: 11
Immunology 32%
2 drugs Phase 3: 6 Phase 2: 4 Phase 1: 13
Oncology 2%
0 drugs Phase 3: 1
Pipeline Strength Pro
Loading...